How hormones like DHT and testosterone drive hair loss, and what that means for treatment choices.
Microneedling is the most evidence-backed adjunct in hair loss, and also the one most men do wrong. Three mistakes flatten results: depth too shallow, frequency too high, and using it as standalone instead of a delivery system.
Topical finasteride is sold as the safer, milder, more local version of the oral pill. The pharmacokinetic data does not support that framing as cleanly as the marketing implies. Evidence-based guide to what topical actually delivers.
Dutasteride suppresses DHT more aggressively than finasteride, but its 4-5 week half-life and broader receptor inhibition reshape the entire risk-benefit conversation. Evidence-based guide on when switching actually makes sense.
Which nutrient deficiencies actually cause hair loss versus which are correlation noise. Iron / ferritin matters most. Biotin is overhyped. The bloodwork panel that answers the question.
Stress does cause hair loss, but almost never the kind men think it does. The shedding panic after a stressful month is telogen effluvium – a temporary, recoverable shift in the hair cycle. The slow loss of density at your…
Ketoconazole shampoo is the most-recommended cheap adjunct in hair loss, and most men get it wrong twice. They buy the 1 percent OTC version and expect prescription-strength results, then they use it like regular shampoo and never give the active…
Most men assume something simple: If finasteride isn’t working, it must be because DHT isn’t low enough. That sounds logical — but it’s not how this condition actually behaves. Finasteride is very effective at what it does. Clinical data consistently…
A system-level explanation for why progress in health, performance, and hair loss becomes inconsistent Introduction: The Pattern Most People Eventually Notice At some point, people who take their health, performance, or appearance seriously begin to notice a pattern that is…
RU58841 vs finasteride: how a topical anti-androgen compares to oral finasteride on DHT blockade, regrowth potential, and systemic risk. An evidence-based breakdown.